Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 55 (representing 20 labs)

Tests names and labsConditionsGenes and analytesMethods

CentoCancer panel

Centogene AG - the Rare Disease Company
Germany
5231
  • C Sequence analysis of the entire coding region

Otogenetics Hereditary Cancers

Otogenetics
United States
3639
  • E Sequence analysis of select exons

Hereditary Cancer Panel - High Penetrance 16

Molecular Genetics Laboratory London Health Sciences Centre
Canada
2816
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Hereditary Cancer Panel Comprehensive

Molecular Genetics Laboratory London Health Sciences Centre
Canada
4030
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Myeloid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
3253
  • X Mutation scanning of select exons

Pancreatic cancer/melanoma syndrome, somatic

Centogene AG - the Rare Disease Company
Germany
11
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

myRisk Hereditary Cancer

Myriad Genetic Laboratories, Inc.
United States
1928
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CDK4. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

CDKN2A. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

CDKN2A. MLPA testing

Instituto de Medicina Genomica
Spain
11
  • D Deletion/duplication analysis

Pancreatic Cancer Sequencing Panel

PreventionGenetics
United States
1312
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Cancer Sequencing and Deletion/Duplication Panel

PreventionGenetics
United States
4335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Melanoma Predisposition via the CDKN2A Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

VistaSeq Colorectal Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
2222
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

VistaSeq Pancreatic Cancer Panel

Molecular Diagnostic Laboratory LabCorp
United States
1414
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

genTrue

True Health Diagnostics
United States
4026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Colorectal/Gastrointestinal Cancer Panel

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
5922
  • E Sequence analysis of select exons

Comprehensive Hereditary Cancer Panel

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
13561
  • E Sequence analysis of select exons

Hereditary Pancreatic Cancer Panel

Baylor Miraca Genetics Laboratories Baylor College of Medicine
United States
4617
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Results: 1 to 20 of 55

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center